FindTrial
Sign In

TREATMENT FOR MALE INFERTILITY

AN OPEN LABELLED RCT STUDY TO ASSESS THE COMBINED EFFECT OF VIRECHANA UTTARABASTI SARIVACHATUSHKA RASAYANA WITH AMRITA PRASHA GHRITA ANUPANA OVER ONLY KUSTA KOKILAKSHADI RASAYANA WITH AMRITA PRASHA GHRITA ANUPANA IN KSHEENA SHUKRA(OLIGOASTHENOZOOSPERMIA) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073818
Enrollment
40
Registered
2024-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

None listed

Sponsors

DR KEDARNATH J
Lead Sponsor
DR KEDARNATH J
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: DIAGNOISED CASE OF OLIGOASTHENOZOOSPERMIA. SPERM COUNT LESS THAN 15 MILLION/ML MOTILITY LESS THAN 40% SUBJECTS WHO WILL SIGN FOR INFORMED CONSENT SUBJECTS FIT FOR VIRECHANA,NIRUHA BASTI , UTTARABASTI

Exclusion criteria

Exclusion criteria: SUBJECTS WITH AZOOSPERMIA SUBJECTS WITH CONGENITAL DISSORDERSRELEATED TO REPRODUCTIVE SYSTEM LIKE BILATERAL ABSENCE OF VASDEFERENCE,CRYPTORCHIDISL,MARFANS SYNDROM,KLINEFELTER SYNDROME

Design outcomes

Primary

MeasureTime frame
IMPROVEMENT IN THE SPERM COUNTTimepoint: 48 DAYS—

Secondary

MeasureTime frame
IMPROVEMENT IN THE OBJECTIVE CRITERIATimepoint: 48 DAYS—

Countries

India

Contacts

Public ContactDR MADHAVA DIGGAVI

TARANATH GOVT AYURVEDIC MEDICAL COLLEGE AND HOSPITAL.BALLARI

drmvdbly@gmail.com9844094290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026